IRCT20220215054031N1招募中2 期
A clinical trial: Comparison of two insulin increasement methods in control of blood glucose in pregnant women with diagnosed diabetes on insulin therapy after betamethasone administration due to threatened preterm labor entering Mahdie hospital between 2021-2022: sliding method with increasing patient’s baseline insulin method
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •Gestational age between 24 to 34 weeks
- •Gestational diabetes on insulin therapy
- •Diabetes type 1 or 2 on insulin therapy
- •Completely controlled blood sugar before entrance to trial
- •Corticosteroid therapy before labor
- •Multiple pregnancy
排除标准
- •Patients unwilling to enter or continue the study
- •Patient refusing admission in our hospital
研究者
相似试验
进行中（未招募）
3 期
A 26-week trial comparing the effect and safety of once weekly insulin icodec and once daily insulin glargine 100 units/mL, both in combination with bolus insulin with or without non-insulin anti-diabetic drugs, in subjects with type 2 diabetes on a basal-bolus regimen. ONWARDS 4.CTRI/2021/06/034231ovo Nordisk Denmark
招募中
不适用
Blood sugar control after bypass operation - insulin vs oral medicatioheart disease, diabetesSLCTR/2014/024ational Hospital of Sri Lanka330
已完成
不适用
Evaluating the effect of a new supplement on recovery after open heart surgeryIRCT201312102480N3Shiraz University of Medical Sciences92
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2EUCTR2013-002878-47-HUovo Nordisk A/S64
进行中（未招募）
不适用
A trial comparing sequential addition of insulin aspart versus further dose increase with insulin degludec/liraglutide in subjects with type 2 diabetes mellitus, previously treated with insulin degludec/liraglutide and metformin and in need of further intensificatioDiabetes Mellitus, Type 2MedDRA version: 16.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2013-002878-47-ESovo Nordisk A/S64